Type 2 & other diabetes

Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps

JAMA Intern MedPublished Cohort study

Authors' conclusion

In this cohort study, a $35 monthly insulin out-of-pocket cap was found to be associated with significantly lower insulin out-of-pocket spending, increased access to insulin, and decreased blood glucose levels among Medicare beneficiaries with T2D. These findings suggest federal cost-sharing policies could improve access and adherence to essential medications in diabetes and other chronic diseases.

Study context

Population
Medicare Part D beneficiaries with T2D in the IQVIA national longitudinal open claims database, 2019–2023; subset with linked ambulatory electronic medical recordsmedian quarterly cohort 1,393,402
Participants
4.8 million beneficiaries
Exposure
Before vs after the $35 monthly insulin out-of-pocket cap
Outcome
Mean quarterly insulin out-of-pocket spending, mean daily units of insulin, mean HbA1c and incidence rates of severe hypoglycemia resulting in hospitalizations or ED visits
Methodological detailsinterrupted time-series analysis, segmented regression with generalized estimating equations, Analysis performed between January and July 2025
  • Interrupted time-series analysis
  • Segmented regression with generalized estimating equations
  • Analysis performed between January and July 2025

Main finding

As reported in the abstract

Mean quarterly insulin out-of-pocket spending

Baseline mean quarterly insulin out-of-pocket spending

$192.66

95% CI $192.63-$192.68

Decline in 2021

$47.90

95% CI -$48.95 to -$46.84

Further decline in 2023

$58.59

95% CI -$59.91 to -$57.27

Observational data: associations, not effects.

Further findings

Mean daily insulin use

Baseline
12.86 (95% CI, 12.86-12.87) units
Increase in 2023
0.23 (95% CI, 0.15-0.31) units

Mean HbA1c (subset with linked electronic medical record data, n = 207 197)

Baseline
7.28% (95% CI, 7.28%-7.28%)
Decrease after 2023
0.06% (95% CI, −0.08% to −0.03%)

Safety

Corresponding modest increases in rates of severe hypoglycemic events

Original publication

Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps. JAMA Intern Med. Published 6 April 2026. doi:10.1001/jamainternmed.2026.0255

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.